NPC VIDEO

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is... Watch Video

RECENT NEWS

Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-... more
Blog Post

#TBT: National Boss’ Day—Celebrating Dan Leonard’s Six Years of Leadership

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
Blog Post

A Day in the Life: Dr. Shih Talks About His NPC-Milken Institute SPH Fellowship

In 2012, the National Pharmaceutical Council (NPC) and the Milken Institute School of Public Health (Milken... more
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications,... more
Newsletter Subpage

Mind the Gap: Improving Quality Measurement in Accountable Care Systems

Join the National Pharmaceutical Council on October 30 in Washington, DC, for a conference, “Mind the Gap:... more
Newsletter Subpage

Patient Access to Medicines: A Growing Challenge

For health care consumers, the rationale for why some medicines are covered by their insurer and others are not... more
Newsletter Subpage

PCORI Round Up: Posting Research Findings, New Committee Members, and Pragmatic Clinical Trials

This month the Patient-Centered Outcomes Research Institute (PCORI) recently announced plans to fund additional... more
Newsletter Subpage

How Do We Define Value? Expert Panel Takes a Closer Look During Tufts CEVR Symposium

Health care value means different things to different people, which is why measuring value is difficult, said... more
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael... more
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health... more
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty... more
Commentary and Testimony Page

Healthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data

March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... more
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... more
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... more
YouTube Videos

Access to Specialty Medications & Value-Based Insurance Design

Specialty medications have been making health care headlines because of their effectiveness and higher costs.... more
YouTube Videos

Consumer-Directed Health Plans

A unique survey of large employers sheds light on the strategies and best practices that they follow when... more
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health... more
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... more
Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-... more
Blog Post

#TBT: National Boss’ Day—Celebrating Dan Leonard’s Six Years of Leadership

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
Blog Post

A Day in the Life: Dr. Shih Talks About His NPC-Milken Institute SPH Fellowship

In 2012, the National Pharmaceutical Council (NPC) and the Milken Institute School of Public Health (Milken... more
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications,... more

PUBLICATION

Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design (V-BID)

V-BID is a key tactic payers and purchasers can use to promote access to high-value specialty medications. This report explains how.
vbid-report

EVENT

Mind the Gap: Improving Quality Measurement

Join us to examine the use of quality measures to balance financial incentives in accountable care systems, gaps in accountable care measure sets, and possible solutions for addressing these gaps.

October 30, 2014
10 am – 3:15 pm ET

 Improving Quality Measurement

Learn More

NEWS

Michael Ciarametaro Joins NPC as Director of Research

Michael will be a valuable addition to NPC’s research efforts, and he comes at an important time as we continue to explore new issues and challenges facing patients and the pharmaceutical industry.” —NPC President Dan Leonard